• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; CARDIAC OCCLUSION DEVICE Back to Search Results
Model Number 9-ASD-034
Device Problems Detachment Of Device Component (1104); Migration or Expulsion of Device (1395)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/20/2014
Event Type  Injury  
Event Description
Using a 12f amplatzer torqvue 45 delivery system (dtv45) to implant a 34mm amplatzer septal occluder (aso), the aso became detached from the dtv45 delivery cable as the aso was retracted into the delivery sheath following multiple attempts to reposition the aso.The delivery cable reportedly prematurely detached from the device causing the aso to embolize into the right atrium where it was snared and removed.No adverse patient effects were reported and a new dtv45 was used to implant a larger aso.
 
Manufacturer Narrative
The 12f dtv45 delivery system, delivery cable, and 34mm aso were returned to sjm and decontaminated.The results of this investigation confirmed the dtv45 delivery cable and aso met all functional and dimensional specifications when analyzed at sjm.There was no evidence to suggest there was an intrinsic defect in the delivery cable or aso, and the cause for the premature release of the aso during the procedure remains unknown.The device history record for both products was reviewed to ensure that each manufacturing and inspection operation was performed.The review determined the process was performed and completed in accordance with sjm specifications and procedures.Information from the field indicated there were multiple attempts to re-position the aso during which turning of the delivery cable can potentially cause it to unscrew from the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
CARDIAC OCCLUSION DEVICE
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key3726791
MDR Text Key4309921
Report Number2135147-2014-00032
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/20/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/04/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date12/31/2018
Device Model Number9-ASD-034
Device Lot Number4452311
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/28/2014
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/20/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/06/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
MODEL 9-ITV12F45/80, LOT 4410640
Patient Outcome(s) Required Intervention;
Patient Age56 YR
Patient Weight57
-
-